We are live on
!
Find out more
PCA
Private Capital Advisors Portfolio holdings
AUM
$1.15B
1-Year Est. Return
43.46%
This Fund
S&P 500
This Quarter
Est. Return
-0.76%
1 Year Est. Return
+43.46%
3 Year Est. Return
+131.91%
5 Year Est. Return
+229.29%
10 Year Est. Return
+757.55%
AUM
$307M
AUM Growth
+$31.9M
(+12%)
Cap. Flow
+$40.1M
Cap. Flow
% of AUM
13.06%
Top 10 Holdings %
Top 10 Hldgs %
24.74%
Holding
140
New
26
Increased
30
Reduced
34
Closed
7
Avg Time Held
5.1
quarters
Top 10 Avg Time Held
2.9
quarters
Top 20 Avg Time Held
4.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
+$9.59M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$6.03M |
| 3 |
GE Aerospace
GE
|
+$5.63M |
| 4 |
Meta Platforms (Facebook)
META
|
+$4.15M |
| 5 |
Comcast
CMCSA
|
+$2.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$4.53M |
| 2 |
MacroGenics
MGNX
|
+$1.86M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$1.43M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$1.26M |
| 5 |
EOG Resources
EOG
|
+$1.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.28% |
| 2 | Communication Services | 20.72% |
| 3 | Energy | 14.2% |
| 4 | Industrials | 11.62% |
| 5 | Technology | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TRIL
1
DELISTED
Trillium Therapeutics Inc.
TRIL
| $11M | 3.59% |
504,562
+420,742
| +502% | +$9.59M |
2015 Q1
1 quarter
|
|
2
Apple
AAPL
$4.98T
| $10.1M | 3.29% |
322,196
-25,384
| -7% | -$812K |
2013 Q2
8 quarters
|
|
|
3
Comcast
CMCSA
$74.1B
| $8.1M | 2.64% |
269,290
+93,690
| +53% | +$2.75M |
2013 Q2
8 quarters
|
|
4
McKesson
MCK
$112B
| $7.6M | 2.48% |
33,806
+331
| +1% | +$76.5K |
2013 Q2
8 quarters
|
|
5
Blackstone
BX
$82.6B
| $7.52M | 2.45% |
187,521
-357
| -0.2% | -$14.7K |
2013 Q2
8 quarters
|
|
6
Enterprise Products Partners
EPD
$77.8B
| $6.95M | 2.26% |
232,459
+38,564
| +20% | +$1.26M |
2013 Q2
8 quarters
|
|
7
LyondellBasell Industries
LYB
$19.4B
| $6.32M | 2.06% |
61,015
+40
| +0.1% | +$4.02K |
2013 Q2
8 quarters
|
|
8
Pfizer
PFE
$162B
| $6.14M | 2% |
193,180
+1,306
| +0.7% | +$42.6K |
2013 Q2
8 quarters
|
|
|
AGTC
9
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $6.1M | 1.99% |
397,757
-125
| -0% | -$2.4K |
2014 Q2
4 quarters
|
|
10
DELISTED
Paramount Global Class B
PARA
| $6.06M | 1.98% |
109,197
-225
| -0.2% | -$13.6K |
2013 Q2
8 quarters
|
|
|
TFCFA
11
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $6.06M | 1.98% |
186,217
+33,777
| +22% | +$1.14M |
2013 Q3
7 quarters
|
|
|
12
GE Aerospace
GE
$319B
| $6.05M | 1.97% |
47,514
+43,382
| +1,050% | +$5.63M |
2013 Q2
8 quarters
|
|
13
Madison Square Garden
MSGS
$9.73B
| $6.01M | 1.96% |
100,938
-2,469
| -2% | -$148K |
2014 Q1
5 quarters
|
|
|
14
Thermo Fisher Scientific
TMO
$245B
| $6M | 1.96% |
+46,230
| New | +$6.03M |
2015 Q2
0 quarters
|
|
15
RTX Corp
RTX
$247B
| $5.96M | 1.94% |
85,409
-419
| -0.5% | -$30.7K |
2013 Q2
8 quarters
|
|
|
DTV
16
DELISTED
DIRECTV COM STK (DE)
DTV
| $5.96M | 1.94% |
64,175
| – | – |
2013 Q2
8 quarters
|
|
17
Union Pacific
UNP
$168B
| $5.92M | 1.93% |
62,045
-325
| -0.5% | -$33.9K |
2013 Q2
8 quarters
|
|
18
Liberty Global Class C
LBTYK
$2.87B
| $5.83M | 1.9% |
142,256
-87
| -0.1% | -$3.6K |
2013 Q2
8 quarters
|
|
19
Alphabet (Google) Class C
GOOG
$4.27T
| $5.52M | 1.8% |
205,960
+858
| +0.4% | +$23K |
2013 Q2
8 quarters
|
|
20
UnitedHealth
UNH
$339B
| $5.45M | 1.78% |
44,636
+205
| +0.5% | +$24.3K |
2014 Q3
3 quarters
|
|
21
Plains All American Pipeline
PAA
$17.6B
| $5.17M | 1.69% |
118,692
+28,469
| +32% | +$1.37M |
2013 Q2
8 quarters
|
|
22
Danaher
DHR
$157B
| $4.92M | 1.6% |
85,522
-357
| -0.4% | -$20.4K |
2013 Q2
8 quarters
|
|
23
Qualcomm
QCOM
$189B
| $4.9M | 1.6% |
78,192
-275
| -0.4% | -$18.8K |
2013 Q3
7 quarters
|
|
24
3M
MMM
$83.9B
| $4.43M | 1.44% |
34,349
-120
| -0.3% | -$16.1K |
2013 Q2
8 quarters
|
|
|
25
Meta Platforms (Facebook)
META
$1.94T
| $4.36M | 1.42% |
+50,798
| New | +$4.15M |
2015 Q2
0 quarters
|
|
Similar funds
WB
AIC
CFP
HT
AA
CIG
CIS
FWM
Private Capital Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, Private Capital Advisors held 140 positions worth $307M, up 12% from $275M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Private Capital Advisors deployed $40.1M of net new capital in Q2 2015, opening 26 new positions and adding to 30 existing holdings. Its largest new stake was Thermo Fisher Scientific: 46,230 shares worth $6M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $4.53M trimmed.
- Private Capital Advisors's largest Q2 2015 buy was Thermo Fisher Scientific: 46,230 shares worth $6M.
- Private Capital Advisors added most to Trillium Therapeutics Inc. in Q2 2015, an estimated $9.59M increase.
- Private Capital Advisors's biggest Q2 2015 reduction was Ionis Pharmaceuticals, cutting an estimated $4.53M.
- Private Capital Advisors fully exited Twitter, Inc. in Q2 2015, selling an estimated $1.43M.
- Private Capital Advisors's ten largest holdings make up 25% of its $307M portfolio in Q2 2015.
- Private Capital Advisors opened 26 new positions and closed 7 in Q2 2015.
- Private Capital Advisors's portfolio value rose 12% quarter-over-quarter to $307M.
Based on Private Capital Advisors's 13F filing for Q2 2015, filed 6 Aug 2015.